News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Direct Flow Medical, Inc. Announces Fifth Patent Issuance of Their Unique Percutaneous Aortic Valve Technology



5/20/2009 9:43:05 AM

SANTA ROSA, Calif.--(BUSINESS WIRE)--Direct Flow Medical, Inc. a privately held, emerging medical device Company developing a next generation, minimally invasive implant to treat patients with heart valve disease announced today the issuance of its 5th patent on their Percutaneous Aortic Valve (PAV) Technology. The patent (USP# 7,534,259) entitled: “Nonstented Heart Valves with Formed in situ Support” provides further protection for this second generation PAV device.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES